1. Home
  2. ETNB vs SPT Comparison

ETNB vs SPT Comparison

Compare ETNB & SPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • SPT
  • Stock Information
  • Founded
  • ETNB 2018
  • SPT 2010
  • Country
  • ETNB United States
  • SPT United States
  • Employees
  • ETNB N/A
  • SPT N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • SPT Computer Software: Prepackaged Software
  • Sector
  • ETNB Health Care
  • SPT Technology
  • Exchange
  • ETNB Nasdaq
  • SPT Nasdaq
  • Market Cap
  • ETNB 1.0B
  • SPT 1.1B
  • IPO Year
  • ETNB 2019
  • SPT 2019
  • Fundamental
  • Price
  • ETNB $6.06
  • SPT $19.64
  • Analyst Decision
  • ETNB Strong Buy
  • SPT Buy
  • Analyst Count
  • ETNB 10
  • SPT 15
  • Target Price
  • ETNB $27.56
  • SPT $32.77
  • AVG Volume (30 Days)
  • ETNB 2.5M
  • SPT 813.9K
  • Earning Date
  • ETNB 05-08-2025
  • SPT 05-08-2025
  • Dividend Yield
  • ETNB N/A
  • SPT N/A
  • EPS Growth
  • ETNB N/A
  • SPT N/A
  • EPS
  • ETNB N/A
  • SPT N/A
  • Revenue
  • ETNB N/A
  • SPT $405,908,000.00
  • Revenue This Year
  • ETNB N/A
  • SPT $12.30
  • Revenue Next Year
  • ETNB N/A
  • SPT $13.09
  • P/E Ratio
  • ETNB N/A
  • SPT N/A
  • Revenue Growth
  • ETNB N/A
  • SPT 21.66
  • 52 Week Low
  • ETNB $4.16
  • SPT $18.72
  • 52 Week High
  • ETNB $11.84
  • SPT $54.40
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 42.57
  • SPT 32.82
  • Support Level
  • ETNB $5.68
  • SPT $18.82
  • Resistance Level
  • ETNB $6.13
  • SPT $20.95
  • Average True Range (ATR)
  • ETNB 0.69
  • SPT 1.56
  • MACD
  • ETNB 0.03
  • SPT 0.03
  • Stochastic Oscillator
  • ETNB 51.62
  • SPT 22.66

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About SPT Sprout Social Inc

Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions.

Share on Social Networks: